{"disease":{"id":"untreated-cd30-positive-hodgkin-s-lymphoma","name":"untreated cd30 positive hodgkin s lymphoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03729609","title":"Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion \"Untreated CD30-Positive Hodgkin's Lymphoma\"","phase":"","overall_status":"COMPLETED","enrollment_count":113,"lead_sponsor_name":"Takeda","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}